Clostridium difficile toxigénico en muestras de heces: nuevo diagnóstico laboratorial

Clostridium difficile (CD) is a gram-positive, strictly anaerobic, spore-forming bacillus, the main causative agent of infectious diarrhea associated with medical care in adults and the use of antimicrobials. C. difficile infection (CDI) is manifested by both factors. main virulence: toxin A (TcdA)...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: Chamba Lapo, Rubby Karolina (author)
Médium: bachelorThesis
Jazyk:spa
Vydáno: 2024
Témata:
On-line přístup:https://dspace.unl.edu.ec/jspui/handle/123456789/29594
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
_version_ 1857833070798831616
author Chamba Lapo, Rubby Karolina
author_facet Chamba Lapo, Rubby Karolina
author_role author
collection Repositorio Universidad Nacional de Loja
dc.contributor.none.fl_str_mv Delgado, Iliana Alicia
dc.creator.none.fl_str_mv Chamba Lapo, Rubby Karolina
dc.date.none.fl_str_mv 2024-04-17T14:08:47Z
2024-04-17T14:08:47Z
2024-04-16
dc.format.none.fl_str_mv 60 p.
application/pdf
dc.identifier.none.fl_str_mv https://dspace.unl.edu.ec/jspui/handle/123456789/29594
dc.language.none.fl_str_mv spa
dc.publisher.none.fl_str_mv Loja
dc.rights.none.fl_str_mv http://creativecommons.org/licenses/by-nc-sa/3.0/ec/
info:eu-repo/semantics/openAccess
dc.source.none.fl_str_mv reponame:Repositorio Universidad Nacional de Loja
instname:Universidad Nacional de Loja
instacron:UNL
dc.subject.none.fl_str_mv LABORATORIO CLÍNICO
CLOSTRIDIUM DIFFICILE
INFECCIONES DIARREICAS
dc.title.none.fl_str_mv Clostridium difficile toxigénico en muestras de heces: nuevo diagnóstico laboratorial
dc.type.none.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/bachelorThesis
description Clostridium difficile (CD) is a gram-positive, strictly anaerobic, spore-forming bacillus, the main causative agent of infectious diarrhea associated with medical care in adults and the use of antimicrobials. C. difficile infection (CDI) is manifested by both factors. main virulence: toxin A (TcdA) and toxin B (TcdB). CD has a hypervirulent strain NAP1/027 associated with high rates of morbidity and mortality. The diagnosis of this infection is confirmed by laboratory, using direct or indirect methods that have different degrees of efficacy and diagnostic effectiveness. The purpose of this study is to identify the prevalence of CD strain NAP1/027 and the best diagnostic method to identify toxigenic Clostridium difficile in stool samples. To this end, it has been proposed to follow the methodology for systematic reviews based on the search for the problem with the guidelines of the Cochrane system and screening the information following the PRISMA method, evaluating the quality of each document using the JBI tool for precision studies. diagnostic tests ensuring that the trials used for this review comply with the guidelines established for their methodology and development, in order to avoid the highest percentage of risk of bias possible. A total of 12 articles were included for this review in which the average prevalence of the toxigenic Clostridium difficile strain NAP1/027 in stool samples worldwide was found to be 25.23% and the best diagnostic method to identify Clostridium toxigenic difficile in stool samples is the single tube method based on the fluorescence readout of the OC-MAB platform (orthogonal CRISPR system combined with multiple RPA). The growing increase in CD infections constitutes a serious health problem if there is no adequate clinical management
eu_rights_str_mv openAccess
format bachelorThesis
id UNL_e16e5bf1e15375da576eef9fdc00c6ee
instacron_str UNL
institution UNL
instname_str Universidad Nacional de Loja
language spa
network_acronym_str UNL
network_name_str Repositorio Universidad Nacional de Loja
oai_identifier_str oai:dspace.unl.edu.ec:123456789/29594
publishDate 2024
publisher.none.fl_str_mv Loja
reponame_str Repositorio Universidad Nacional de Loja
repository.mail.fl_str_mv *
repository.name.fl_str_mv Repositorio Universidad Nacional de Loja - Universidad Nacional de Loja
repository_id_str 0
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-sa/3.0/ec/
spelling Clostridium difficile toxigénico en muestras de heces: nuevo diagnóstico laboratorialChamba Lapo, Rubby KarolinaLABORATORIO CLÍNICOCLOSTRIDIUM DIFFICILEINFECCIONES DIARREICASClostridium difficile (CD) is a gram-positive, strictly anaerobic, spore-forming bacillus, the main causative agent of infectious diarrhea associated with medical care in adults and the use of antimicrobials. C. difficile infection (CDI) is manifested by both factors. main virulence: toxin A (TcdA) and toxin B (TcdB). CD has a hypervirulent strain NAP1/027 associated with high rates of morbidity and mortality. The diagnosis of this infection is confirmed by laboratory, using direct or indirect methods that have different degrees of efficacy and diagnostic effectiveness. The purpose of this study is to identify the prevalence of CD strain NAP1/027 and the best diagnostic method to identify toxigenic Clostridium difficile in stool samples. To this end, it has been proposed to follow the methodology for systematic reviews based on the search for the problem with the guidelines of the Cochrane system and screening the information following the PRISMA method, evaluating the quality of each document using the JBI tool for precision studies. diagnostic tests ensuring that the trials used for this review comply with the guidelines established for their methodology and development, in order to avoid the highest percentage of risk of bias possible. A total of 12 articles were included for this review in which the average prevalence of the toxigenic Clostridium difficile strain NAP1/027 in stool samples worldwide was found to be 25.23% and the best diagnostic method to identify Clostridium toxigenic difficile in stool samples is the single tube method based on the fluorescence readout of the OC-MAB platform (orthogonal CRISPR system combined with multiple RPA). The growing increase in CD infections constitutes a serious health problem if there is no adequate clinical managementClostridium difficile (CD) es un bacilo grampositivo, estrictamente anaeróbico, formador de esporas, principal agente causante de diarreas infecciosas asociadas a la atención médica en adultos y al uso de antimicrobianos La infección por C. difficile (ICD) se manifiesta por los dos factores de virulencia principales: la toxina A (TcdA) y la toxina B (TcdB). CD posee una cepa hipervirulenta NAP1/027 asociada a altas tasas de morbilidad y mortalidad. El diagnóstico de esta infección se lo confirma mediante laboratorio, utilizando métodos directos o indirectos que presentan distintos grados de eficacia y efectividad diagnóstica. La finalidad de este estudio es identificar la prevalencia de la cepa NAP1/027 de CD y el mejor método de diagnóstico para identificar Clostridium difficile toxigénico en muestras de heces. Con tal efecto, se ha planteado seguir la metodología para revisiones sistemáticas partiendo de la búsqueda del problema con las pautas del sistema Cochrane y el cribado la información siguiendo el método PRISMA, evaluando la calidad de cada documento mediante la herramienta JBI para estudios de precisión de pruebas diagnósticas asegurando que los ensayos utilizados para esta revisión cumplan con las pautas establecidas para su metodología y desarrollo, con la finalidad de evitar el mayor porcentaje de riesgo de sesgo posible. Se incluyeron un total de 12 artículos para esta revisión en los que se encontró la media de prevalencia de la cepa NAP1/027 de Clostridium difficile toxigénico en muestras de heces a nivel mundial de 25,23% y el mejor método de diagnóstico para identificar Clostridium difficile toxigénico en muestras de heces es el método de tubo único basado en la lectura de fluorescencia de la plataforma OC-MAB (sistema CRISPR ortogonal combinado con múltiples RPA). El creciente aumento de infecciones por CD constituye un problema serio de salud si no existe el manejo clínico adecuadoLojaDelgado, Iliana Alicia2024-04-17T14:08:47Z2024-04-17T14:08:47Z2024-04-16info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesis60 p.application/pdfhttps://dspace.unl.edu.ec/jspui/handle/123456789/29594spahttp://creativecommons.org/licenses/by-nc-sa/3.0/ec/info:eu-repo/semantics/openAccessreponame:Repositorio Universidad Nacional de Lojainstname:Universidad Nacional de Lojainstacron:UNL2025-05-02T15:56:01Zoai:dspace.unl.edu.ec:123456789/29594Institucionalhttps://dspace.unl.edu.ec/Universidad públicahttps://unl.edu.ec/https://dspace.unl.edu.ec/oaiEcuador***opendoar:02025-05-02T15:56:01falseInstitucionalhttps://dspace.unl.edu.ec/Universidad públicahttps://unl.edu.ec/https://dspace.unl.edu.ec/oai*Ecuador***opendoar:02025-05-02T15:56:01Repositorio Universidad Nacional de Loja - Universidad Nacional de Lojafalse
spellingShingle Clostridium difficile toxigénico en muestras de heces: nuevo diagnóstico laboratorial
Chamba Lapo, Rubby Karolina
LABORATORIO CLÍNICO
CLOSTRIDIUM DIFFICILE
INFECCIONES DIARREICAS
status_str publishedVersion
title Clostridium difficile toxigénico en muestras de heces: nuevo diagnóstico laboratorial
title_full Clostridium difficile toxigénico en muestras de heces: nuevo diagnóstico laboratorial
title_fullStr Clostridium difficile toxigénico en muestras de heces: nuevo diagnóstico laboratorial
title_full_unstemmed Clostridium difficile toxigénico en muestras de heces: nuevo diagnóstico laboratorial
title_short Clostridium difficile toxigénico en muestras de heces: nuevo diagnóstico laboratorial
title_sort Clostridium difficile toxigénico en muestras de heces: nuevo diagnóstico laboratorial
topic LABORATORIO CLÍNICO
CLOSTRIDIUM DIFFICILE
INFECCIONES DIARREICAS
url https://dspace.unl.edu.ec/jspui/handle/123456789/29594